Venous thromboembolism and prognosis in cancer

Khorana, 2003, Malignancy, thrombosis and Trousseau: the case for an eponym, J Thromb Haemost, 1, 2463, 10.1111/j.1538-7836.2003.00501.x

Khorana, 2006, Thromboembolism in hospitalized neutropenic cancer patients, J Clin Oncol, 24, 484, 10.1200/JCO.2005.03.8877

Caine, 2002, The hypercoagulable state of malignancy: pathogenesis and current debate, Neoplasia, 4, 465, 10.1038/sj.neo.7900263

Heit, 2002, Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study, Arch Intern Med, 162, 1245, 10.1001/archinte.162.11.1245

Cavo, 2002, Deep-vein thrombosis in patients with multiple myeloma receiving first-line thalidomide-dexamethasone therapy, Blood, 100, 2272, 10.1182/blood-2002-06-1674

Kuenen, 2003, Potential role of platelets in endothelial damage observed during treatment with cisplatin, gemcitabine, and the angiogenesis inhibitor SU5416, J Clin Oncol, 21, 2192, 10.1200/JCO.2003.08.046

Kabbinavar, 2003, Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer, J Clin Oncol, 21, 60, 10.1200/JCO.2003.10.066

Khorana, 2007, Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients, Cancer, 110, 2339, 10.1002/cncr.23062

Browder, 2000, The hemostatic system as a regulator of angiogenesis, J Biol Chem, 275, 1521, 10.1074/jbc.275.3.1521

Rickles, 2003, Tissue factor, thrombin, and cancer, Chest, 124, 58S, 10.1378/chest.124.3_suppl.58S

Kuderer, 2009, Impact of venous thromboembolism and anticoagulation on cancer and cancer survival, J Clin Oncol, 27, 4902, 10.1200/JCO.2009.22.4584

Khorana, 2007, Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy, J Thromb Haemost, 5, 632, 10.1111/j.1538-7836.2007.02374.x

Fotopoulou, 2008, Incidence of venous thromboembolism in patients with ovarian cancer undergoing platinum/paclitaxel-containing first-line chemotherapy: an exploratory analysis by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group, J Clin Oncol, 26, 2683, 10.1200/JCO.2008.16.1109

Kuderer, 2008, Venous thromboembolism and all-cause mortality in cancer patients receiving chemotherapy, J Clin Oncol, 26, 9521, 10.1200/jco.2008.26.15_suppl.9521

Khorana, 2008, Development and validation of a predictive model for chemotherapy-associated thrombosis, Blood, 111, 4902, 10.1182/blood-2007-10-116327

Kuderer, 2008, Venous Thromboembolism Risk Model Predicts Early Progression and Overall Mortality in Cancer Patients Receiving Chemotherapy, Blood, 172

Sorensen, 2000, Prognosis of cancers associated with venous thromboembolism, N Engl J Med, 343, 1846, 10.1056/NEJM200012213432504

Chew, 2006, Incidence of venous thromboembolism and its effect on survival among patients with common cancers, Arch Intern Med, 166, 458, 10.1001/.458

Gross, 2007, The impact of venous thromboembolism on risk of death or hemorrhage in older cancer patients, J Gen Intern Med, 22, 321, 10.1007/s11606-006-0019-x

Chew, 2007, Incidence of venous thromboembolism and the impact on survival in breast cancer patients, J Clin Oncol, 25, 70, 10.1200/JCO.2006.07.4393

Chew, 2008, The incidence of venous thromboembolism among patients with primary lung cancer, J Thromb Haemost, 6, 601, 10.1111/j.1538-7836.2008.02908.x

Alcalay, 2006, Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival, J Clin Oncol, 24, 1112, 10.1200/JCO.2005.04.2150

Komrokji, 2006, Venous thromboembolism in patients with diffuse large B-cell lymphoma, Leuk Lymphoma, 47, 1029, 10.1080/10428190600560991

Ku, 2009, Venous thromboembolism in patients with acute leukemia: incidence, risk factors, and effect on survival, Blood, 113, 3911, 10.1182/blood-2008-08-175745

Han, 2006, Preoperative serum tissue factor levels are an independent prognostic factor in patients with ovarian carcinoma, J Clin Oncol, 24, 755, 10.1200/JCO.2005.02.9181

Nitori, 2005, Prognostic significance of tissue factor in pancreatic ductal adenocarcinoma, Clin Cancer Res, 11, 2531, 10.1158/1078-0432.CCR-04-0866

Zangari, 2003, Thalidomide and deep vein thrombosis in multiple myeloma: risk factors and effect on survival, Clin Lymphoma, 4, 32, 10.3816/CLM.2003.n.011

Zangari, 2007, Effect on survival of treatment-associated venous thromboembolism in newly diagnosed multiple myeloma patients, Blood Coagul Fibrinolysis, 18, 595, 10.1097/MBC.0b013e3281067fb2